The natriuretic peptide/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice by Kuhn, Michaela et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
BMC Pharmacology
Open Access Oral presentation
The natriuretic peptide/guanylyl cyclase-A system functions as a 
stress-responsive regulator of angiogenesis in mice
Michaela Kuhn*1, Kristine Schwarz1, Michael Hartmann1, Javier Carbajo-
Lozoya2, Ulrich Flögel3, Jörg Stypmann4, Martin van Eickels5, 
Stepan Gambaryan6, Thomas Wieland2 and Hideo A Baba7
Address: 1Institute of Physiology, University of Würzburg, Germany, 2Institute of Experimental and Clinical Pharmacology and Toxicology, 
University of Heidelberg, Mannheim, Germany, 3Department of Cardiovascular Physiology, Heinrich-Heine-University of Düsseldorf, Germany, 
4Department of Cardiology and Angiology, University Hospital Münster, Germany, 5Institute of Physiology II, Rheinische Friedrich-Wilhelms-
University of Bonn, Germany, 6Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Germany and 7Institute of 
Pathology and Neuropathology, University of Duisburg-Essen, Essen, Germany
Email: Michaela Kuhn* - michaela.kuhn@mail.uni-wuerzburg.de
* Corresponding author    
Background
Cardiac atrial natriuretic peptide (ANP) and B-type natri-
uretic peptide (BNP) modulate blood pressure and vol-
ume by activation of the receptor guanylyl cyclase-A (GC-
A) and subsequent intracellular cGMP formation. Here we
report what we believe to be a novel function of these pep-
tides as paracrine regulators of vascular regeneration.
Results
In mice with systemic deletion of the GC-A gene, vascular
regeneration in response to critical hindlimb ischemia
was severely impaired. Similar attenuation of ischemic
angiogenesis and arteriogenesis was observed in mice
with conditional, endothelial cell-restricted GC-A  dele-
tion (termed here EC GC-A KO mice). In contrast, smooth
muscle cell-restricted GC-A  ablation did not affect
ischemic neovascularization. Immunohistochemistry and
RT-PCR analyses of mRNA obtained from laser-microdis-
sected cells revealed BNP expression in activated satellite
cells within the ischemic muscle, suggesting that local
BNP elicits these protective endothelial effects. To verify
these results, we studied BNP mRNA expression in cul-
tured C2C12 cells, a mouse myoblast cell line. Quantita-
tive real time RT-PCR demonstrated that BNP mRNA was
strongly expressed in C2C12 cells and was induced by
hypoxia. Taken together these in vivo/in vitro data suggest
that expression of BNP induced in activated satellite cells
of the ischemic muscle stimulates angiogenesis via
endothelial GC-A.
Cardiac hypertrophy and angiogenesis are coordinately
regulated during physiological or adaptive cardiac growth.
ANP and especially BNP are among the earliest and most
sensitive stress-responsive "fetal genes" induced in cardio-
myocytes in response to pressure overload. To test
whether this cardiac induction of NPs participates in the
regulation of coronary angiogenesis, EC GC-A KO mice
and respective control littermates where subjected to
transverse aortic constriction (TAC). The induced pressure
gradient (~50 mmHg) and the load-provoked increases in
left ventricular mass were similar in EC GC-A KO mice and
controls. Left ventricular systolic function was not altered,
as fractional shortening and ejection fraction remained
optimal. However, in contrast to the control mice, EC GC-
A KO mice developed significant left ventricular diastolic
dysfunction. Histological analyses showed that hearts
from EC GC-A KO mice exhibit mild fibrosis, as assessed
by sirius red staining. Assessment of capillary and
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endothelial content by isolectin stainings revealed a sig-
nificant decrease in EC GC-A KO compared to control
hearts. These observations indicate that endothelial GC-A
activation participates in angiogenesis during the early
compensatory phase of pathologic hypertrophy.
Lastly, the functional responses to ANP and BNP were
studied in spontaneously immortalized, well character-
ized microvascular endothelial cells from rat epididymal
fat pad capillaries (RFPEC). BNP increased intracellular
cGMP content and activated cGMP-dependent protein
kinase I as well as the phosphorylation of vasodilator-
stimulated phosphoprotein and p38 MAPK. BNP stimu-
lated proliferation, migration and angiogenic sprouting of
RFPEC with a similar concentration-dependency. These
pro-angiogenic responses were largely suppressed in the
presence of Rp-8-pCPT-cGMPs, a specific PKG I inhibitor.
ANP, but not c-ANP-(4–23), a ligand for the NP clearance
receptor (NPR-C), exerted similar effects than BNP. Nota-
bly, the maximal NP-induced pro-angiogenic effects were
as strong as those evoked by vascular endothelial growth
factor (VEGF-A, 50 ng/ml).
Conclusion
We conclude that BNP, produced by activated satellite
cells within ischemic skeletal muscle or by cardiomyo-
cytes in response to pressure-load, regulates the regenera-
tion of neighboring endothelia via GC-A. This paracrine
communication might be critically involved in coordinat-
ing muscle regeneration/hypertrophy and angiogenesis.
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